A new vaccine appears to be extending the lives of patients with a deadly type of brain cancer called Glioblastoma.
Researchers found that when adding the vaccine to surgery, radiation and chemotherapy, the average patient's survival time after diagnosis increased from 15 months to 26 months.
"It educates the immune system to produce antibodies, or magic bullets, to find the tumor and help the immune system target the tumor very specifically," Dr. John Sampson, a professor of Neurosurgery at Duke University, said.
Glioblastoma is the most common form of brain cancer. There are nearly 10,000 new cases of it in the U.S. each year. This vaccine is only for patients who have a genetic mutation.
A Phase Three clinical trial is planned for the vaccine before possibly being made available on the market.
KKTV firmly believes in freedom of speech for all and we are happy to provide this forum for the community to share opinions and facts. We ask that commenters keep it clean, keep it truthful, stay on topic and be responsible. Comments left here do not necessarily represent the viewpoint of KKTV 11 News.
If you believe that any of the comments on our site are inappropriate or offensive, please tell us by clicking “Report Abuse” and answering the questions that follow. We will review any reported comments promptly.powered by Disqus